Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | YTHDC1 | Q96MU7 | 12/20 | 0.76 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.55 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.55 |
| ▸ | PDE8A | O60658 | 1/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.53 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.53 |
| ▸ | PPARD | Q03181 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3394076 | 0.88 | HSP90AB1 (0.68) | YTHDC1ADORA2AADORA1HSP90AA1HSP90AB1 | |
| SCHEMBL27388305 | 0.86 | YTHDC1 (1.00) | YTHDC1 | |
| SCHEMBL3821565 | 0.86 | YTHDC1 (0.57) | YTHDC1ADORA2APDE8AHSP90AA1HSP90AB1 | |
| SCHEMBL5458724 | 0.84 | YTHDC1 (0.61) | YTHDC1ADORA2AADORA1TP53RXFP1 | |
| SCHEMBL5451873 | 0.84 | YTHDC1 (0.72) | YTHDC1ADORA2AADORA1PDE8A | |
| SCHEMBL30898205 | 0.84 | YTHDC1 (0.72) | YTHDC1ADORA2AADORA1PDE8A | |
| SCHEMBL5465712 | 0.82 | ADORA2A (0.79) | YTHDC1ADORA2AADORA1 | |
| SCHEMBL183057 | 0.82 | YTHDC1 (0.68) | YTHDC1ADORA2A | |
| SCHEMBL30898278 | 0.82 | YTHDC1 (0.68) | YTHDC1ADORA2A | |
| SCHEMBL22345236 | 0.81 | YTHDC1 (0.56) | YTHDC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070203159-A1 | Purine compounds | UNIVERSITETET I OLSO (NO) | 2007-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203159-A1 | Purine compounds | PNP, UMPS, TYMP | YTHDC1 632/4885ADORA2A 96/4885ADORA1 149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.